MetLife Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.2M | Sell |
49,683
-1,916
| -4% | -$711K | 0.09% | 194 |
|
|
2026
Q1 | $15.1M | Sell |
51,599
-1,680
| -3% | -$552K | 0.08% | 250 |
|
|
2025
Q4 | $18.7M | Sell |
53,279
-2,608
| -5% | -$881K | 0.09% | 177 |
|
|
2025
Q3 | $18.1M | Buy |
+55,887
| New | +$17.4M | 0.09% | 198 |
|
|
2025
Q2 | – | Sell |
-61,871
| Closed | -$26.9M | – | 2868 |
|
|
2025
Q1 | $26.9M | Sell |
61,871
-1,166
| -2% | -$468K | 0.15% | 104 |
|
|
2024
Q4 | $23.3M | Buy |
63,037
+1,032
| +2% | +$432K | 0.13% | 118 |
|
|
2024
Q3 | $32.2M | Sell |
62,005
-1,719
| -3% | -$918K | 0.18% | 85 |
|
|
2024
Q2 | $34.5M | Buy |
63,724
+7,362
| +13% | +$3.89M | 0.21% | 78 |
|
|
2024
Q1 | $29.2M | Sell |
56,362
-2,019
| -3% | -$1M | 0.2% | 82 |
|
|
2023
Q4 | $27.5M | Sell |
58,381
-1,250
| -2% | -$578K | 0.2% | 85 |
|
|
2023
Q3 | $26M | Sell |
59,631
-1,854
| -3% | -$841K | 0.2% | 81 |
|
|
2023
Q2 | $27.3M | Sell |
61,485
-3,126
| -5% | -$1.44M | 0.2% | 86 |
|
|
2023
Q1 | $29.7M | Sell |
64,611
-109
| -0.2% | -$51.9K | 0.21% | 78 |
|
|
2022
Q4 | $33.2M | Sell |
64,720
-1,431
| -2% | -$727K | 0.25% | 70 |
|
|
2022
Q3 | $30M | Sell |
66,151
-1,191
| -2% | -$570K | 0.25% | 67 |
|
|
2022
Q2 | $32.5M | Buy |
67,342
+1,869
| +3% | +$925K | 0.25% | 68 |
|
|
2022
Q1 | $32.2M | Buy |
65,473
+12,459
| +24% | +$5.7M | 0.21% | 85 |
|
|
2021
Q4 | $24.6M | Sell |
53,014
-1,264
| -2% | -$532K | 0.2% | 86 |
|
|
2021
Q3 | $20.2M | Sell |
54,278
-1,692
| -3% | -$643K | 0.18% | 97 |
|
|
2021
Q2 | $21.4M | Sell |
55,970
-1,597
| -3% | -$610K | 0.19% | 94 |
|
|
2021
Q1 | $20.7M | Sell |
57,567
-2,025
| -3% | -$651K | 0.19% | 94 |
|
|
2020
Q4 | $19.1M | Sell |
59,592
-3,347
| -5% | -$1.03M | 0.18% | 95 |
|
|
2020
Q3 | $16.9M | Sell |
62,939
-2,445
| -4% | -$658K | 0.19% | 96 |
|
|
2020
Q2 | $17.2M | Buy |
65,384
+24
| +0% | +$6.4K | 0.2% | 94 |
|
|
2020
Q1 | $14.8M | Sell |
65,360
-1,999
| -3% | -$545K | 0.2% | 96 |
|
|
2019
Q4 | $20.3M | Sell |
67,359
-2,258
| -3% | -$621K | 0.21% | 85 |
|
|
2019
Q3 | $16.7M | Sell |
69,617
-1,277
| -2% | -$350K | 0.18% | 103 |
|
|
2019
Q2 | $20M | Sell |
70,894
-148,298
| -68% | -$40.5M | 0.21% | 82 |
|
|
2019
Q1 | $62.9M | Buy |
219,192
+145,222
| +196% | +$42M | 0.19% | 84 |
|
|
2018
Q4 | $19.4M | Sell |
73,970
-1,653
| -2% | -$455K | 0.24% | 80 |
|
|
2018
Q3 | $20.7M | Buy |
75,623
+498
| +0.7% | +$129K | 0.21% | 83 |
|
|
2018
Q2 | $17.9M | Sell |
75,125
-1,832
| -2% | -$424K | 0.21% | 81 |
|
|
2018
Q1 | $16.9M | Sell |
76,957
-2,487
| -3% | -$584K | 0.2% | 95 |
|
|
2017
Q4 | $17.9M | Buy |
+79,444
| New | +$16.9M | 0.2% | 91 |
|
Other funds holding ELV
MetLife Investment Management's ELV Position: Q2 2026 in Review
MetLife Investment Management reduced its Elevance Health (ELV) stake by 3.7% in Q2 2026, selling an estimated $711K and leaving 49,683 shares worth $19.2M. The position accounts for 0.09% of the portfolio, ranked #194.
MetLife Investment Management first reported a position in ELV in Q4 2017 and has held it in 34 quarters since. The position peaked at $62.9M in Q1 2019. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- MetLife Investment Management held 49,683 shares of Elevance Health worth $19.2M as of Q2 2026.
- MetLife Investment Management sold 1,916 Elevance Health shares in Q2 2026, an estimated $711K.
- Elevance Health made up 0.09% of MetLife Investment Management's portfolio in Q2 2026, its #194 holding.
- MetLife Investment Management first reported a position in Elevance Health in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Elevance Health position peaked at $62.9M in Q1 2019.
- 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.